Jayasinghe C, Simiantonaki N, Michel-Schmidt R, Kirkpatrick C J
Institute of Pathology, Johannes Gutenberg University, 55101 Mainz, Germany.
Oncol Rep. 2009 Nov;22(5):1093-100. doi: 10.3892/or_00000541.
Vascular endothelial growth factor receptor 3 (VEGFR-3) is a major inducer of lymphangiogenic signalling and seems to be involved also in angiogenesis. Since both processes are closely linked with tumor metastasis this study investigated the expression of VEGFR-3 in tumor-associated vessels in colorectal carcinomas and evaluated its relevance for lymphogenous and hematogenous metastasis. In a comparative study between microvascular endothelial cells isolated from the tumor (HCTEC) and the corresponding non-neoplastic tissue (HCMEC) from five patients with colorectal cancer VEGFR-3 expression was measured using a specific ELISA. The expression pattern was individually different, with cases showing reduced, elevated and unchanged protein levels. Under hypoxic culture conditions (3% O2 for 24 h), which are more realistic for the tumor situation, the levels remained unchanged. In contrast, hypoxia exposure of macrovascular human umbilical vein endothelial cells (HUVEC) led to a consistent downregulation of VEGFR-3 protein. These data indicate a 'hypoxia-resistant' behaviour of VEGFR-3 in colonic microvasculature. Using immunohistochemistry the endothelial expression pattern of VEGFR-3 in 74 non-metastatic, lymphogenously-metastatic and hematogenously-metastatic colorectal carcinoma specimens was assessed. Positive VEGFR-3 expression was highly significantly associated with those cases showing distant metastasis (p=0.0003). In contrast, significant differences in the expression of VEGFR-3 between non-metastatic tumors and carcinomas with lymph node metastasis were not found. The majority of the detectable intratumoral VEGFR-3-positive vessels were of blood vascular origin (CD31 positive, D2-40 negative). Whereas intratumoral lymphatic vessels were collapsed, VEGFR-3 positive peritumoral lymphatic vessels had mostly open lumina. These morphological observations provide evidence for a predominant significance of VEGFR-3-positive, possibly angiogenesis-mediated, tumor-associated blood vessels in hematogenous metastasis of colorectal cancer. In addition, due to their patency VEGFR-3-positive peritumoral, but not intratumoral lymphatics could be the vascular substrate functionally mediating lymphogenous metastasis.
血管内皮生长因子受体3(VEGFR - 3)是淋巴管生成信号的主要诱导因子,似乎也参与血管生成。由于这两个过程都与肿瘤转移密切相关,本研究调查了VEGFR - 3在结直肠癌肿瘤相关血管中的表达,并评估了其与淋巴转移和血行转移的相关性。在一项比较研究中,从5例结直肠癌患者的肿瘤组织(HCTEC)和相应的非肿瘤组织(HCMEC)中分离出微血管内皮细胞,使用特异性酶联免疫吸附测定法(ELISA)检测VEGFR - 3的表达。其表达模式个体差异较大,病例显示蛋白水平降低、升高和不变。在更接近肿瘤实际情况的低氧培养条件下(3%氧气,24小时),水平保持不变。相比之下,大血管人脐静脉内皮细胞(HUVEC)暴露于低氧环境会导致VEGFR - 3蛋白持续下调。这些数据表明VEGFR - 3在结肠微血管中具有“抗低氧”行为。使用免疫组织化学方法评估了74例非转移性、淋巴转移性和血行转移性结直肠癌标本中VEGFR - 3的内皮表达模式。VEGFR - 3阳性表达与出现远处转移的病例高度显著相关(p = 0.0003)。相比之下,未发现非转移性肿瘤与有淋巴结转移的癌之间VEGFR - 3表达有显著差异。大多数可检测到的肿瘤内VEGFR - 3阳性血管起源于血管(CD31阳性,D2 - 40阴性)。肿瘤内淋巴管塌陷,而肿瘤周围VEGFR - 3阳性淋巴管大多管腔开放。这些形态学观察结果为VEGFR - 3阳性、可能由血管生成介导的肿瘤相关血管在结直肠癌血行转移中的主要意义提供了证据。此外,由于其通畅性,肿瘤周围VEGFR - 3阳性淋巴管而非肿瘤内淋巴管可能是在功能上介导淋巴转移的血管基础。